# Convalescent Plasma in the Treatment of Covid-19

> **NCT04730401** · PHASE2 · UNKNOWN · sponsor: **Helsinki University Central Hospital** · enrollment: 390 (estimated)

## Conditions studied

- Covid19

## Interventions

- **BIOLOGICAL:** Convalescent plasma from COVID-19 donors
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04730401
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-27
- **Primary completion:** 2022-01-30
- **Final completion:** 2023-01-30
- **Target enrollment:** 390 (ESTIMATED)
- **Last updated:** 2022-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04730401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04730401, "Convalescent Plasma in the Treatment of Covid-19". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04730401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*